KAZIA THERAPEUTICS LTD

KZIAReported to SECin USCIK 0001075880Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 7. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 7
Form 4 lines at KAZIA THERAPEUTICS LTD, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Coffey Steven R. S.—Awardnothing paid100,000 sharesJul 8, 2026Coffey Steven R. S.nothing paidAward · Jul 8Award100,000Jul 8, 2026
Friend John E. IIChief Executive OfficerAwardnothing paid150,000 sharesJul 8, 2026Friend John E. IIChief Executive Officernothing paidAward · Jul 8Award150,000Jul 8, 2026
Friend John E. IIChief Executive OfficerAwardnothing paid500,000 sharesJul 8, 2026Friend John E. IIChief Executive Officernothing paidAward · Jul 8Award500,000Jul 8, 2026
Bonacorda JeffreyVP, Finance and ControllerAwardnothing paid150,000 sharesJul 8, 2026Bonacorda JeffreyVP, Finance and Controllernothing paidAward · Jul 8Award150,000Jul 8, 2026
Davidson Ebru—Awardnothing paid100,000 sharesJul 8, 2026Davidson Ebrunothing paidAward · Jul 8Award100,000Jul 8, 2026